Twitter | Search | |
Search Refresh
Frontiers Oncology Feb 6
We're partnering with The 2nd Lung Cancer Summit (), hosted by & . Don't miss out, registration is now open - Recent discoveries, world-class medical oncologists in the field of treatment at .
Reply Retweet Like
Kathryn Mileham Nov 15
Thanks to our survivors for getting our day started with passion and purpose!
Reply Retweet Like
Mehrpouya Mobin Mar 27
🚨 Medical education in is more important now than ever. Join the virtually on the 15th of May. A truly fantastic faculty awaits you. Registration is free!
Reply Retweet Like
Katsuaki Maehara Ph.D. 🇯🇵 May 15
This is my opinion. EGFR-TKI mono or +chemo combi are important patient’s selection. Considerate efficacy and toxicity + cost + QOL + patient’s requests…
Reply Retweet Like
Alfredo Addeo MD May 16
Reply Retweet Like
Katsuaki Maehara Ph.D. 🇯🇵 May 15
It was a very productive summit. I've learned a lot. Thank you very much. Stay safe everyone !
Reply Retweet Like
Dr. Antonio Calles 🌈😷 #QuédateEnCasa May 15
🎯 Always have in mind an ablative therapy for patients with oligometastasic mutant lung cancer.
Reply Retweet Like
Jose Fernando Moura, MD, PhD May 6
All together to maintain the best care for the lung cancer patients and up to date during the
Reply Retweet Like
International Lung Cancer Summit May 21
We had a truly fantastic virtual conference on latest developments in lung cancer & mesothelioma at the 2020! You missed it or would simply like to dive in again? No problem, you can re-watch all sessions for free at as often as you like!
Reply Retweet Like
Penn Medicine MD Feb 26
last week -- we spy 's on that speaker list! ⬇️👏 Dr. Bauml will present at the 2nd International 2020 this Spring in Geneva, Switzerland: "Personalized Medicine With IO: Can We Tailor Immunotherapy Options To Patients?"
Reply Retweet Like
International Lung Cancer Summit May 22
Due to time constraints, we could not address every question from our participants at the . We would like to make up for this and will post some of the questions here on Twitter in the coming days... stay tuned!
Reply Retweet Like
Kenn Samala May 15
Thank you, for all those informative sessions! Learned a lot from colleagues all over the world. Congratulations
Reply Retweet Like
Kenn Samala May 15
Replying to @Keniji
Nodal Immune Flare: apparent radiographic progression after neoadjuvant ICIs with pathologic response
Reply Retweet Like
Liz Cramer Feb 27
Reply Retweet Like
Dr Anne-Marie Baird May 15
Reply Retweet Like
Stephen V Liu May 15
IO in localized lung cancer discussion led by . Important reminder of the disconnect between radiographic and pathologic findings when we integrate neoadjuvant immunotherapy for
Reply Retweet Like
Dr Anne-Marie Baird May 15
Sorry to have missed your talk on SCLC - just getting back in for the last two talks
Reply Retweet Like
Kenn Samala May 15
Replying to @Keniji
Use of immune check point blockade in the neoadjuvant setting remains experimental (can be done in the clinical trial setting)
Reply Retweet Like
Paloma Sosa May 15
Challenges for in COVID era. Hypofractionate? Delay? Interrupt? Also raising awarness about the risk of delaying medical assistance. Dr André Durham
Reply Retweet Like
Paloma Sosa May 15
Lung cancer treatment in COVID era. What should we be prioritizing? Dr Giuseppe Banna.
Reply Retweet Like